Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Assets (2023 - 2025)

Historic Assets for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $67.7 million.

  • Rallybio's Assets fell 1436.08% to $67.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.7 million, marking a year-over-year decrease of 1436.08%. This contributed to the annual value of $68.1 million for FY2024, which is 4109.32% down from last year.
  • Latest data reveals that Rallybio reported Assets of $67.7 million as of Q3 2025, which was down 1436.08% from $51.0 million recorded in Q2 2025.
  • Over the past 5 years, Rallybio's Assets peaked at $162.3 million during Q1 2023, and registered a low of $51.0 million during Q2 2025.
  • For the 3-year period, Rallybio's Assets averaged around $97.7 million, with its median value being $92.4 million (2024).
  • Data for Rallybio's Assets shows a peak YoY increase of 1436.08% (in 2025) and a maximum YoY decrease of 4482.05% (in 2025) over the last 5 years.
  • Rallybio's Assets (Quarter) stood at $115.6 million in 2023, then plummeted by 41.09% to $68.1 million in 2024, then fell by 0.66% to $67.7 million in 2025.
  • Its last three reported values are $67.7 million in Q3 2025, $51.0 million for Q2 2025, and $58.0 million during Q1 2025.